Medicine chapters
Ulcerative colitis and Crohn disease
The two main inflammatory bowel diseases compared: where they strike, how they look, extra-intestinal features, investigations, acute severe colitis, drug treatment, surgery and cancer risk.
- Ulcerative colitis (UC) is continuous mucosal inflammation that always starts in the rectum and gives bloody diarrhoea; Crohn disease (CD) is patchy transmural inflammation anywhere from mouth to anus, classically the terminal ileum, with skip lesions, granulomas, strictures, fistulas and perianal disease.
- Smoking protects against UC but worsens CD; PSC is linked with UC.
- Mild–moderate UC is treated with 5-ASA; flares need steroids; acute severe colitis needs IV hydrocortisone, then ciclosporin/infliximab or colectomy; maintenance uses thiopurines and biologics.
On this page
Overview
Inflammatory bowel disease (IBD) means chronic, relapsing inflammation of the gut. The two main forms are ulcerative colitis (UC) and Crohn disease (CD). A small group with colitis that cannot be classed as either is called IBD unclassified (indeterminate colitis).
IBD usually starts in young adults (peak about 20–40 years). It is less common in Pakistan than in the West but is being diagnosed more often. Here the key practical point is that intestinal TB, amoebic colitis and infective diarrhoea must always be excluded first.
Aetiology
IBD results from an abnormal immune response to gut bacteria in a genetically susceptible person, triggered by environmental factors.
- Genetics: family history is the strongest risk factor. NOD2 (CARD15) gene variants are linked to ileal Crohn disease; HLA-B27 to sacroiliitis.
- Smoking: increases the risk and severity of Crohn disease but is protective against UC (UC often appears after stopping smoking).
- Appendicectomy at a young age appears to protect against UC.
- NSAIDs can trigger onset or flares. Breast-feeding may protect.
- Immune mechanism: excess Th1/Th17 activity and TNF-α, which is why anti-TNF drugs work.
"Crohn and Cigarettes go together; UC is Unusual in smokers."
Pathology: UC versus Crohn
| Feature | Ulcerative colitis | Crohn disease |
|---|---|---|
| Site | Colon and rectum only (backwash ileitis possible) | Anywhere, mouth to anus; terminal ileum and right colon commonest |
| Rectum | Always involved | Often spared |
| Distribution | Continuous from the rectum upwards | Patchy, skip lesions |
| Depth | Mucosa (and superficial submucosa) | Transmural (full thickness) |
| Mucosa | Red, friable, bleeds on touch; pseudopolyps | Aphthous then deep fissuring ulcers; cobblestone appearance |
| Bowel wall | Thin; shortened, featureless colon in long disease | Thick, narrowed; creeping fat |
| Granulomas | Absent | Non-caseating granulomas (about half of cases) |
| Crypts | Crypt abscesses, goblet cell depletion | Less marked; goblet cells preserved |
| Strictures | Rare (a stricture suggests cancer) | Common |
| Fistulas | Rare | Common (enteric, bladder, vagina, skin) |
| Perianal disease | Rare | Common (fissures, fistulas, abscesses, skin tags) |
| Serology | pANCA often positive | ASCA often positive |
Extent of UC (Montreal)
- E1 Proctitis: rectum only.
- E2 Left-sided (distal) colitis: up to the splenic flexure.
- E3 Extensive colitis / pancolitis: beyond the splenic flexure.
Clinical features
Ulcerative colitis
- Bloody diarrhoea with mucus; urgency, tenesmus, nocturnal stools.
- Proctitis: fresh blood and mucus, frequent small stools, often formed; few systemic symptoms.
- Extensive colitis: many liquid bloody stools a day, cramps, fever, weight loss, anaemia.
- Course of relapses and remissions.
- Examination: often little; blood on rectal examination; tachycardia and fever mean a severe attack.
Crohn disease
- Diarrhoea, abdominal pain and weight loss (the main triad); fatigue, fever, anorexia.
- Small bowel disease: colicky pain from subacute obstruction, right iliac fossa pain or mass, malabsorption and steatorrhoea; may mimic appendicitis.
- Colonic disease: bloody diarrhoea, like UC.
- Perianal disease (in about a quarter it is the first sign): fissures, fistulas, abscesses, skin tags.
- Mouth ulcers.
- Children: growth failure and delayed puberty.
- Progression over time from inflammatory to stricturing and penetrating (fistulising) disease.
Extra-intestinal manifestations
| System | Features | Related to bowel activity? |
|---|---|---|
| Joints | Peripheral arthritis type 1 (few large joints) | Yes, flares with colitis |
| Type 2 (many small joints) | No; runs its own course | |
| Sacroiliitis, ankylosing spondylitis (HLA-B27) | No | |
| Skin | Erythema nodosum | Yes |
| Pyoderma gangrenosum | Usually yes, but may be independent | |
| Eyes | Episcleritis | Yes |
| Uveitis | Often independent | |
| Liver and biliary | Primary sclerosing cholangitis (PSC) (mainly UC), fatty liver, gallstones (CD) | No for PSC |
| Kidney | Oxalate stones (CD), uric acid stones | Linked to ileal disease/resection |
| Blood | Venous thromboembolism, anaemia (iron, B12, folate, chronic disease) | Higher in flares |
| Bone | Osteoporosis (steroids, low vitamin D) |
PSC is most associated with UC. It does not follow bowel activity, is not cured by colectomy, and increases the risk of cholangiocarcinoma and colon cancer.
Terminal ileal Crohn disease or resection leads to B12 deficiency, bile salt malabsorption, gallstones (bile salt loss) and oxalate kidney stones (fat binds calcium in the gut, so more oxalate is absorbed).
Investigations
Blood tests
- Anaemia, raised platelets, ESR and CRP (CRP rises more in Crohn), low albumin in severe disease.
- Iron studies, B12 and folate, liver tests (PSC).
- pANCA (UC) and ASCA (CD) are supportive only.
Stool tests
- Stool culture and C. difficile toxin in every flare; stool microscopy for amoebae (very important in Pakistan).
- Faecal calprotectin: raised in active gut inflammation; helps separate IBD from IBS and is used to monitor disease.
Endoscopy and biopsy
- Ileocolonoscopy with multiple biopsies is the key diagnostic test for both.
- UC: continuous inflammation from the rectum, loss of vascular pattern, friability, ulcers, pseudopolyps.
- CD: patchy aphthous or deep ulcers, cobblestoning, ileal involvement, rectal sparing.
- In a severe attack, do only a limited unprepared flexible sigmoidoscopy; full colonoscopy risks perforation.
- Upper GI endoscopy if symptoms suggest proximal Crohn disease.
Imaging
- Plain abdominal X-ray in acute severe colitis: colonic dilatation (toxic megacolon), mucosal islands, thumbprinting.
- MR enterography (or CT, barium follow-through, small bowel ultrasound) for small bowel Crohn: thick ileum, strictures with dilatation above, fistulas, abscesses. The narrowed terminal ileum may show the "string sign" of Kantor.
- Barium enema in long-standing UC: loss of haustra and a narrow, smooth "lead-pipe" colon; collar-stud ulcers in active disease.
- Pelvic MRI for perianal fistulas; capsule endoscopy when small bowel imaging is normal but suspicion remains.
In Pakistan, ileocaecal TB can look exactly like Crohn disease. Biopsy, culture and GeneXpert of tissue, chest X-ray and CT nodes help. Never start steroids or anti-TNF drugs without excluding TB.
Acute severe ulcerative colitis
Truelove and Witts criteria
Severe = more than 6 bloody stools a day plus at least one sign of systemic illness:
- Temperature over 37.5 °C
- Pulse over 90/min
- Haemoglobin under 100 g/L
- ESR over 30 mm/h (or raised CRP)
Low albumin (under 30 g/L) is an additional marker of severity.
8 bloody stools/day, temperature 38.0 °C, pulse 104, Hb 112 g/L, ESR 42 mm/h
Stools: 8 > 6 → yes
Systemic signs: 38.0 > 37.5 (yes), 104 > 90 (yes), Hb 112 not under 100 (no), ESR 42 > 30 (yes) → 3 signs
→ Acute severe colitis: admit for IV steroids
Day 3 on IV hydrocortisone: 9 stools/day (more than 8) → high risk of colectomy; start rescue therapy or plan surgery
Management
- Admit under joint medical and surgical care.
- Exclude infection: stool culture, C. difficile, amoebae; biopsy for CMV if refractory.
- IV hydrocortisone 100 mg four times daily (6-hourly).
- IV fluids, correct potassium and anaemia (transfuse if needed), nutritional support.
- Prophylactic low molecular weight heparin: IBD carries a high clot risk, even with rectal bleeding.
- Stop anticholinergics, opioids, antidiarrhoeals and NSAIDs (they can precipitate toxic megacolon).
- Daily stool chart, pulse, temperature, CRP, FBC, electrolytes; daily abdominal X-ray if not improving.
- Day 3 review: if CRP over 45 mg/L or more than 8 stools a day, start rescue therapy with IV ciclosporin or infliximab, or proceed to colectomy.
- If no response to rescue treatment: subtotal colectomy with end ileostomy, leaving the rectum.
Toxic megacolon
- Colon dilated to more than 6 cm (usually the transverse colon) on plain X-ray, with systemic toxicity.
- Risk of perforation, which has a high mortality; steroids can mask the signs.
- A falling stool frequency with increasing distension is a danger sign, not improvement.
- Needs urgent surgery if it does not resolve quickly on intensive treatment.
In acute severe UC, a falling stool count with a swelling, tender abdomen may mean toxic dilatation, not recovery; check a plain X-ray and involve the surgeons early.
Drug treatment
Main drug groups
| Drug | Use | Key points |
|---|---|---|
| 5-ASA (aminosalicylates): mesalazine, sulfasalazine, balsalazide, olsalazine | First-line for mild–moderate UC, induction and maintenance | Little benefit in Crohn. Sulfasalazine (sulfapyridine part) causes reversible low sperm count, rash, haemolysis; 5-ASA can rarely cause nephritis |
| Corticosteroids: prednisolone, IV hydrocortisone, budesonide | Induce remission in moderate–severe flares | Not for maintenance. Budesonide for mild–moderate ileocaecal Crohn (fewer side-effects). Avoid in perianal sepsis or abscess |
| Thiopurines: azathioprine, mercaptopurine | Maintain remission, steroid-sparing | Check TPMT first; regular blood counts (bone marrow suppression), liver tests, pancreatitis |
| Methotrexate | Maintenance in Crohn | Weekly dose; teratogenic |
| Anti-TNF: infliximab, adalimumab, golimumab | Moderate–severe or steroid-refractory disease; fistulising Crohn; rescue in acute severe UC | Screen for TB and hepatitis B first; risk of infection, demyelination, lymphoma |
| Other biologics: vedolizumab (gut-selective α4β7 integrin), ustekinumab (IL-12/23) | When anti-TNF fails or is unsuitable | |
| Tofacitinib (oral JAK inhibitor) | Moderate–severe UC | |
| Ciclosporin IV | Rescue in acute severe UC | Monitor levels, kidneys, BP |
| Antibiotics (metronidazole, ciprofloxacin) | Perianal Crohn, abscess, pouchitis |
Ulcerative colitis by extent
- Proctitis: rectal 5-ASA (suppositories) first; add oral 5-ASA; steroids if no response.
- Left-sided colitis: 5-ASA enemas plus oral 5-ASA; oral prednisolone if not settling.
- Extensive colitis: oral 5-ASA (plus rectal); oral prednisolone for moderate flares.
- Maintenance: 5-ASA for most; azathioprine after a severe attack or frequent steroid use; biologics for refractory disease.
Crohn disease
- Stop smoking: the single most useful step.
- Induction: oral prednisolone (or IV for severe); budesonide for mild–moderate ileocaecal disease; exclusive enteral nutrition (first-line in children).
- Maintenance: azathioprine/mercaptopurine or methotrexate; anti-TNF for poor-prognosis, refractory or fistulising disease, often combined with a thiopurine.
- Perianal disease: drain sepsis (seton), antibiotics, then thiopurine and/or anti-TNF.
- Treat deficiencies: iron, B12 injections after ileal resection, vitamin D.
Steroids induce remission but do not maintain it. Long courses cause osteoporosis, diabetes and infection; use steroid-sparing drugs.
Surgery
Ulcerative colitis (surgery is curative)
Indications: acute severe colitis failing medical treatment, toxic megacolon, perforation, massive haemorrhage; chronic disease with poor control or steroid dependence; dysplasia or cancer on surveillance; growth failure in children.
- Emergency: subtotal colectomy with end ileostomy, keeping the rectum.
- Elective: restorative proctocolectomy with ileal pouch–anal anastomosis (IPAA), or panproctocolectomy with permanent ileostomy.
- Pouchitis affects about a third of pouch patients; treat with metronidazole and/or ciprofloxacin.
Crohn disease (surgery is not curative)
Indications: obstruction from strictures, fistulas, abscesses, perforation, bleeding, failed medical treatment, growth failure.
- Keep resections short (risk of short bowel syndrome); use strictureplasty for short strictures.
- Recurrence after surgery is common, usually at the anastomosis; stop smoking.
- An ileal pouch is not advised in Crohn disease because of high pouch failure.
Complications and prognosis
- Toxic megacolon, perforation, haemorrhage (UC).
- Strictures, fistulas, abscesses, malabsorption, short bowel (CD).
- Bowel (colon and rectal) cancer risk in long-standing extensive UC and extensive Crohn colitis; higher with longer duration, greater extent, PSC, ongoing inflammation and a family history. Regular colonoscopic surveillance is advised for extensive colitis lasting more than about 10 years.
- Small bowel adenocarcinoma and lymphoma (rare, CD).
- Venous thromboembolism.
- Most patients have a normal life expectancy with good care; about a third of UC patients have only one attack.
Expect: UC versus Crohn table (rectum, continuity, depth, granulomas, crypt abscesses, fistulas, perianal disease, skip lesions), smoking effects, NOD2, extra-intestinal features and which follow disease activity, PSC with UC, gallstones and oxalate stones after ileal disease, toxic megacolon over 6 cm, Truelove and Witts criteria, management of acute severe colitis (IV hydrocortisone, LMWH, day-3 rescue with ciclosporin or infliximab, colectomy), 5-ASA as first-line in UC, sulfasalazine and male infertility, TPMT before azathioprine, TB screening before anti-TNF, indications for surgery, pouchitis, and cancer surveillance.
Quick revision
- UC: rectum always, continuous, mucosal, bloody diarrhoea, crypt abscesses, pANCA.
- CD: mouth to anus, skip lesions, transmural, granulomas, fistulas, perianal disease, ASCA.
- Smoking protects in UC, harms in CD.
- PSC goes with UC; gallstones and oxalate stones with ileal CD.
- Severe UC: more than 6 bloody stools/day plus fever, tachycardia, anaemia or high ESR.
- Treat severe UC: IV hydrocortisone, LMWH, exclude infection; day 3 rescue or colectomy.
- Toxic megacolon: over 6 cm, risk of perforation.
- 5-ASA first-line in mild–moderate UC; steroids induce, do not maintain.
- TPMT before azathioprine; TB screen before anti-TNF.
- UC surgery is curative; Crohn surgery is not.
Written by The House Job from standard references (Kumar and Clark's Clinical Medicine; Bailey & Love's Short Practice of Surgery).
FAQ
What is the single most useful feature separating Crohn disease from ulcerative colitis on biopsy?
Transmural inflammation with non-caseating granulomas points to Crohn disease, whereas UC shows superficial mucosal inflammation with crypt abscesses and goblet cell depletion.
Why are patients with acute severe colitis given heparin despite bleeding?
IBD flares carry a high risk of venous thromboembolism, and prophylactic low molecular weight heparin is safe and recommended.
What should be done before starting infliximab?
Screen for latent tuberculosis (chest X-ray and interferon-gamma release assay or tuberculin test) and hepatitis B, because anti-TNF drugs can reactivate them.
Is colectomy curative in ulcerative colitis?
Yes for the bowel disease, because UC affects only the colon and rectum, although PSC and some extra-intestinal problems may continue.